Feelings of early fullness lower appetite nausea vomiting diarrhea.
Glp 1 side effects.
Low blood sugar levels hypoglycemia are a more serious risk linked to the glp 1 class of medications.
Bleeding blistering burning coldness discoloration of the skin feeling of pressure hives infection inflammation itching lumps numbness pain rash redness scarring soreness stinging swelling tenderness tingling ulceration or warmth at the injection site other side effects not listed may also occur in some patients.
These aes were generally dose dependent and mild in severity.
The most frequently reported treatment emergent adverse events aes were decreased appetite and gastrointestinal aes constipation diarrhea abdominal discomfort abdominal distension vomiting and nausea.
Other common adverse effects include injection site reactions headache and nasopharyngitis but these effects do not usually result in discontinuation of the drug.
Glp 1 ras commonly cause digestive side effects such as.
The most common symptoms associated with the use of glp 1 receptor agonists are gastrointestinal symptoms mainly nausea.
Incretin mimetics are a relatively new group of injectable drugs for treatment of type 2 diabetes.
Pain at the site of injection.
But the risk of low blood sugar levels is usually only increased if you re taking another medication known to lower blood sugar at the same time such as sulfonylureas or insulin.
Side effects of incretin mimetics include.
Change in taste loss of taste.
Inflammation of the pancreas pancreatitis which may be severe is another side effect.